AELIX Therapeutics was awarded a NEOTEC grant

AELIX Therapeutics was awarded a NEOTEC grant
By VR | November 14, 2017

AELIX Therapeutics was awarded a NEOTEC grant by Centre for Industrial Technological Development (CDTI), the entity of Spanish Ministry of Economy, Industry and Competitiveness, for the biannual project “Desarrollo Clínico Inmunógeno HTI” (SNEO-20171166).

The grant of 212.500€ will finance the activity related to developing a new therapeutic vaccine for HIV infection, from late preclinical stages to clinical proof-of-concept studies. Specifically, the grant will support the development of the HIVACAT T-Cell immunogen in a Chimpanzee Adenovirus vector to induce a strong immune response that can lead to a functional cure in people living with HIV infection